All Stories

  1. Haemoglobin as a biomarker for clinical outcomes in chronic obstructive pulmonary disease

    Article • ERJ Open Research, June 2021, European Respiratory Society (ERS)

    Robert Wise

  2. Treatment of exacerbations as a predictor of subsequent outcomes in patients with COPD

    Article • International Journal of Chronic Obstructive Pulmonary Disease, April 2018, Dove Medical Press

    Peter Calverley, Achim Mueller, Robert Wise

  3. The development of AZD7624 for prevention of exacerbations in COPD: a randomized controlled trial

    Article • International Journal of Chronic Obstructive Pulmonary Disease, March 2018, Dove Medical Press

    Robert Palmér, ziad taib, Steven Greenaway, danen cunoosamy, Robert Wise

  4. Seasonal variations in exacerbations and deaths in patients with COPD during the TIOSPIR® trial

    Article • International Journal of Chronic Obstructive Pulmonary Disease, February 2018, Dove Medical Press

    Peter Calverley, Robert Wise

  5. Determinants of exacerbation risk in patients with COPD in the TIOSPIR study

    Article • International Journal of Chronic Obstructive Pulmonary Disease, November 2017, Dove Medical Press

    Peter Calverley, Achim Mueller, Kay Tetzlaff, Robert Wise

  6. How investigators differ in determining cause of death for COPD patients

    Article • ERJ Open Research, January 2017, European Respiratory Society (ERS)

    Achim Mueller, Robert Wise

  7. Differences in outcomes between GOLD groups in patients with COPD in the TIOSPIR® trial

    Article • International Journal of Chronic Obstructive Pulmonary Disease, January 2016, Dove Medical Press

    Peter Calverley, Robert Wise

  8. Prevalence and risk factors for unrecognized obstructive lung disease among urban drug users

    Article • International Journal of Chronic Obstructive Pulmonary Disease, January 2011, Taylor & Francis

    Robert Wise